DDI | Jotup

BlueCat accelerates IT network automation and orchestration with Integrity 9.5

Retrieved on:

Wednesday, April 5, 2023

Version 9.5, now available generally, has greatly enhanced RESTful APIs to further automate network and configuration management across complex network environments.

Key Points:

Version 9.5, now available generally, has greatly enhanced RESTful APIs to further automate network and configuration management across complex network environments.
Many BlueCat customers have already embraced automation, eliminating more than 90% of manual DDI tasks .
This hinders scalability and reliability, makes networks less secure, and is an obstacle to automation and orchestration.
Accelerate automation: Scale network infrastructure management by using our enhanced RESTful APIs to automate tasks related to DDI.

HRCI Named ISA 2023 Business of the Year

Retrieved on:

Tuesday, March 28, 2023

Learning, Intrepid, Creative leadership, Culture, Business, DDI, Organizational culture, United States Army Capabilities Integration Center, HRSI, VitalSource, ISA, Management

ALEXANDRIA, Va., March 28, 2023 (GLOBE NEWSWIRE) -- HRCI® , the premier HR credentialing and learning organization for the human resources profession, today shared that it was recently named the ISA 2023 Business of Year.

Key Points:

ALEXANDRIA, Va., March 28, 2023 (GLOBE NEWSWIRE) -- HRCI® , the premier HR credentialing and learning organization for the human resources profession, today shared that it was recently named the ISA 2023 Business of Year.
HRCI was presented with the award at ISA - The Association of Learning Providers ’ Annual Business Retreat in Scottsdale, Ariz., on March 21, 2023.
With the win for 2023, HRCI joins previous recipients, including Integrity Center for Creative Leadership, Crisis Prevention Institute, DDI, Solutions, ExperiencePoint, Intrepid by VitalSource and many more.
HRCI is thrilled to be this year’s ISA Business of the Year.”

Texas Prices Now Shown Separately in the Official Healthcare Pricing Guide™ (HPG) Texas Release

Retrieved on:

Thursday, March 16, 2023

Benchmark, CPR, Kaiser Family Foundation, Texas Association, CORPUS, DDI, HPG, The Dallas Morning News, Catalysis, Patient, ODG, Kaiser, Benchmarking, PRS, Pharmaceutical industry, Health insurance, Medicare

CORPUS CHRISTI, Texas, March 16, 2023 /PRNewswire/ -- Denniston Data Inc. (DDI), "The Healthcare Transparency Company," has launched a Texas version of the Official Healthcare Pricing Guide™ (HPG), U.S. Medical Benchmark Prices from Transparency in Coverage and Medicare Data, with the largest and most accurate data available on negotiated medical prices in the U.S.

Key Points:

Texas Has Been Paying Higher Medical Prices than the Rest of the U.S.
The national average is 224% of Medicare, so the outpatient negotiated rates in Texas are 36% higher than the national average.
This amount is not commensurate with local costs in Texas, which tend to be lower than national costs.
Rather, using the national tools in the Official Healthcare Pricing Guide™ (HPG) could fix the problem.

EQS-News: VR Equitypartner GmbH: VR Equitypartner supports Cygna Labs in the acquisition of Nokia’s DDI business unit

Retrieved on:

Thursday, March 16, 2023

Diamond, Acquisition, DZ, DDI, Fortune 500, Telecom, Maintenance, Labs, NCC Group, NCC, EUR, Growth, Corporate finance, VR, BT Group, Hakea cygna, Security (finance), Video game

Cygna Labs will be supported by Frankfurt-based private equity company VR Equitypartner (VREP), which holds a minority stake in the company.

Key Points:

Cygna Labs will be supported by Frankfurt-based private equity company VR Equitypartner (VREP), which holds a minority stake in the company.
Cygna Labs is a leading software developer in the fields of network, cloud and security and one of the top three global DDI vendors.
The product will remain a standalone product line and has already been incorporated into Cygna Labs’ portfolio of managed service offerings.
Alexander Häcker, CEO of Cygna Labs Group, notes: “Cygna Labs continues to support large-scale enterprise customers that rely on our DDI products and services.

DDI (DNS, DHCP, and IPAM) Solutions Global Market Report 2023: Trend towards BYOD Provides Opportunity for Growth - ResearchAndMarkets.com

Retrieved on:

Thursday, March 9, 2023

Technology, Networks, COVID-19, Service, Growth, DNS, DHCP, IPAM, DDI, Pet industry

The "DDI (DNS, DHCP, and IPAM) Solutions: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "DDI (DNS, DHCP, and IPAM) Solutions: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Solutions, one of the segments analyzed in the report, is projected to record 28.5% CAGR and reach US$5.6 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 21.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $340.9 Million, While China is Forecast to Grow at 33.7% CAGR
The DDI (DNS, DHCP, and IPAM) Solutions market in the U.S. is estimated at US$340.9 Million in the year 2022.

The Global DNS DHCP IP Address Management (DDI) Market is forecast to grow by $730.59 mn during 2022-2027, accelerating at a CAGR of 16.68% during the forecast period

Retrieved on:

Wednesday, March 8, 2023

Cloud, TCP, DNS, ApplianSys, Mouse, Research, IP, IP address management, Microsoft, DDI, Cisco, NCC, Cryptocurrency, Retail

This study identifies the growing adoption of managed security services as one of the prime reasons driving the DNS DHCP IP Address Management (DDI) market growth during the next few years.

Key Points:

This study identifies the growing adoption of managed security services as one of the prime reasons driving the DNS DHCP IP Address Management (DDI) market growth during the next few years.
Also, need to streamline IP address management and evolution to ipv6 from the ipv4 internet protocol will lead to sizable demand in the market.
Our report on the DNS DHCP IP Address Management (DDI) market covers the following areas:
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading DNS DHCP IP Address Management (DDI) market vendors that include Adweb Technologies Pvt.
Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Cygna Labs Signs Definitive Agreement to Acquire Nokia's DDI Business Unit

Retrieved on:

Tuesday, March 7, 2023

Shift, Cloud, Fortune 500, DNS, Acquisition, Research, Intellectual property, Growth, Face, IDC, DDI, 24/7 service, Hakea cygna, Maintenance, Business, Automation, Fine chemical

MIAMI, March 7, 2023 /PRNewswire-PRWeb/ -- Cygna Labs, a highly specialized software developer focused on serving enterprises worldwide and a leading provider of DDI, cloud security, and compliance technology, announced today that it has entered into a definitive agreement to acquire Nokia's VitalQIP product, related intellectual property as well as its customers and associated personnel.

Key Points:

Christian Ehrenthal, president and CEO, Cygna Labs Corp., said: "Adding Nokia's leading DDI product enhances our intellectual property and will place Cygna Labs in the number two market share position.
Brandon Butler, research manager, IDC, said: "Cygna Labs' acquisition of the VitalQIP DDI business is a significant advancement for the company, as well as the broader DDI market.
Integrating the VitalQIP DDI product into Cygna Labs' portfolio gives the company a broad range of DDI offerings for enterprises and service providers.
Combined with the company's strong managed services for DDI, the acquisition enhances and solidifies Cygna Labs' standing in the DDI market."

Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19

Retrieved on:

Thursday, February 23, 2023

ISM3312 is a highly selective 3CLpro inhibitor with a novel molecular structure optimized from compounds designed by Chemistry42, Insilico’s generative chemistry AI platform.

Key Points:

ISM3312 is a highly selective 3CLpro inhibitor with a novel molecular structure optimized from compounds designed by Chemistry42, Insilico’s generative chemistry AI platform.
ISM3312 has a novel molecular structure that provides broad anti-coronavirus activity, excellent single agent oral bioavailability, and potential drug-resistant mutations.
Insilico Medicine, a clinical-stage biotech company powered by generative AI, today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for ISM3312, an orally available 3CLpro inhibitor generated and designed with the support of Insilico’s proprietary generative chemistry platform Chemistry42 for the treatment of COVID-19.
“Generative AI is transforming every area of human development,” says Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine.

Atea Pharmaceuticals Presents Favorable Drug Interaction Profile of Bemnifosbuvir in Phase 1 Studies at CROI 2023

Retrieved on:

Thursday, February 23, 2023

BOSTON, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that data from three Phase 1 studies suggest a favorable drug-drug interaction profile. No dosage adjustment is needed for CYP3A substrates or for drugs that are sensitive substrates of efflux and hepatic uptake transporters when co-administrated with bemnifosbuvir. CYP3A is an enzyme that metabolizes many classes of prescribed medicines and medicinal supplements, and efflux/hepatic uptake transporters regulate cellular trafficking of many drugs that are commonly prescribed to patients that are at high risk for severe COVID-19.

Key Points:

BOSTON, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that data from three Phase 1 studies suggest a favorable drug-drug interaction profile.
No dosage adjustment is needed for CYP3A substrates or for drugs that are sensitive substrates of efflux and hepatic uptake transporters when co-administrated with bemnifosbuvir.
These results were presented at the Conference on Retroviruses and Opportunistic Infections (CROI), which took place February 19-22, 2023 in Seattle, Washington.
A single dose (simultaneous or staggered) of bemnifosbuvir 1100 mg administered with ROSU slightly increased the plasma exposure of ROSU.

New DDI Study Reveals Largest Drop in Leadership Confidence in a Decade

Retrieved on:

Wednesday, February 8, 2023

Growth, Organization, Science and technology in Asia, Fear, Woman, Burnout, Analytics, Environment, Trust, Weakness, DDI, Interface (computing), Management

PITTSBURGH, Pa., Feb. 8, 2023 /PRNewswire/ -- DDI, a global leadership consulting firm, today released its 2023 Global Leadership Forecast, the largest and longest-running global study on the current and future state of leadership. This year's study found only 40% of leaders reported their company to have high-quality leaders – reflecting a 17% drop from just two years ago and the biggest decline in a decade. That puts current leadership quality ratings nearly on par with those in the wake of the 2007-2008 economic crisis.

Key Points:

PITTSBURGH, Pa., Feb. 8, 2023 /PRNewswire/ -- DDI , a global leadership consulting firm, today released its 2023 Global Leadership Forecast , the largest and longest-running global study on the current and future state of leadership.
With faltering confidence and leadership burnout at record height, DDI's study pinpoints the factors deterring great talent from pursuing leadership roles and provides companies with actionable insights for overcoming those challenges to build an agile leadership bench that drives growth.
The report reveals that half of CEOs say developing the next generation of leaders is a top challenge for their organization.
Only 12% of companies report confidence in the strength of their bench, creating a huge obstacle to growth.